183
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Seroprevalence of Epstein-Barr virus and cytomegalovirus infections in Presidente Figueiredo, Amazonas, Brazil

, , ORCID Icon, ORCID Icon, , & ORCID Icon show all

References

  • de Melo Silva, J.; Pinheiro-Silva, R.; Dhyani, A.; Pontes, G. S. Cytomegalovirus and Epstein-Barr Infections: Prevalence and Impact on Patients with Hematological Diseases. Biomed Res. Int. 2020, 2020, 1–14. DOI: https://doi.org/10.1155/2020/1627824.
  • Cannon, M. J.; Schmid, D. S.; Hyde, T. B. Review of Cytomegalovirus Seroprevalence and Demographic Characteristics Associated with Infection. Rev. Med. Virol. 2010, 20(4), 202–213. DOI: https://doi.org/10.1002/rmv.655.
  • Kang, M. S.; Kieff, E. Epstein–Barr Virus Latent Genes. Exp. Mol. Med. 2015, 47, e131.
  • Mocarski, E. S.;. Immunomodulation by Cytomegaloviruses: Manipulative Strategies beyond Evasion. Trends Microbiol. 2002, 10(7), 332–339. DOI: https://doi.org/10.1016/S0966-842X(02)02393-4.
  • Fagundes, C. P.; Jaremka, L. M.; Glaser, R.; Alfano, C. M.; Povoski, S. P.; Lipari, A. M.; Agnese, D. M.; Yee, L. D.; Carson, W. E.; Farrar, W. B.; Malarkey, W. B.; Chen, M.; Kiecolt-Glaser, J. K. Attachment Anxiety Is Related to Epstein-Barr Virus Latency. Brain. Behav. Immun. 2014,41, 232–238. DOI: https://doi.org/10.1016/j.bbi.2014.04.002.
  • Al-Omari, A.; Aljamaan, F.; Alhazzani, W.; Salih, S.; Arabi, Y. Cytomegalovirus Infection in Immunocompetent Critically Ill Adults: Literature Review. Ann. Intensive Care. 2016, 6(1), 1–14. DOI: https://doi.org/10.1186/s13613-016-0207-8.
  • Blazquez-Navarro, A.; Dang-Heine, C.; Wittenbrink, N.; Bauer, C.; Wolk, K.; Sabat, R.; Westhoff, T. H.; Sawitzki, B.; Reinke, P.; Thomusch, O.; et al. BKV, CMV, and EBV Interactions and Their Effect on Graft Function One Year Post-Renal Transplantation: Results from a Large Multi-Centre Study. EBioMedicine. 2018, 34, 113–121. DOI: https://doi.org/10.1016/j.ebiom.2018.07.017.
  • Bell, A.; Rickinson, A. B. Epstein-Barr Virus, the TCL-1 Oncogene and Burkitt’s Lymphoma. Trends Microbiol. 2003, 11(11), 495–497.
  • Jha, H. C.; Pei, Y.; Robertson, E. S. Epstein-barr Virus: Diseases Linked to Infection and Transformation. Front. Microbiol. 2016, 7(8), 1602.
  • Ito, Y.; Shibata-Watanabe, Y.; Kawada, J.; Maruyama, K.; Yagasaki, H.; Kojima, S.; Kimura, H. Cytomegalovirus and Epstein-Barr Virus Coinfection in Three Toddlers with Prolonged Illnesses. J. Med. Virol. 2009, 81, 1399–1402. DOI: https://doi.org/10.1002/jmv.21527.
  • Lam, J. K. P.; Azzi, T.; Hui, K. F.; Wong, A. M. G.; McHugh, D.; Caduff, N.; Chan, K. H.; Munz, C.; Chiang, A. K. S. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56dimNKG2A+KIR− NK Cells and Contributes to Suboptimal Control of EBV in Immunosuppressed Children with Post-transplant Lymphoproliferative Disorder. Front. Immunol. 2020, 11, 1–12. DOI: https://doi.org/10.1016/j.ijid.2020.01.044.
  • Wang, X.; Yang, K.; Wei, C.; Huang, Y.; Zhao, D. Coinfection with EBV/CMV and Other Respiratory Agents in Children with Suspected Infectious Mononucleosis. Virol. J. 2010, 7(1), 1–10.
  • Gianella, S.; Moser, C.; Vitomirov, A.; McKhann, A.; Layman, L.; Scott, B.; Caballero, G.; Lada, S.; Bosch, R. J.; Hoenigl, M.; Laurain, N.; Landay, A.; Lederman, M. M.; Hunt, P. W.; Smith, D. Presence of Asymptomatic CMV and EBV DNA in Blood of Persons with HIV Starting Antiretroviral Therapy are Associated with Non-AIDS Clinical Events. AIDS. 2021, 34(6), 849–857.
  • Delaney, A. S.; Thomas, W.; Balfour, H. H. Coprevalence of Epstein-Barr Virus, Cytomegalovirus, and Herpes Simplex Virus Type-1 Antibodies among United States Children and Factors Associated with Their Acquisition. J. Pediatric Infect. Dis. Soc. 2015, 4(4), 323–329. DOI: https://doi.org/10.1093/jpids/piu076.
  • Balfour, H. H.; Sifakis, F.; Sliman, J. A.; Knight, J. A.; Schemeling, D. O.; Thomas, W. Age-Specific Prevalence of Epstein-barr Virus Infection among Individuals Aged 6-19 Years in the United States and Factors Affecting Its Acquisition. J. Infect. Dis. 2013, 208(8), 1286–1293.
  • Fourcade, G.; Germi, R.; Guerber, F.; Lupo, J.; Baccard, M.; Seigneurin, A.; Semenova, T.; Morand, P.; Epaulard, O. Evolution of EBV Seroprevalence and Primary Infection Age in a French Hospital and a City Laboratory Network, 2000-2016. PLoS One. 2017, 12(4), e0175574.
  • Kuri, A.; Jacobs, B. M.; Jacobs, B. M.; Vickaryous, N.; Pakpoor, J.; Middeldorp, J.; Giovannoni, G.; Dobson, R.; Dobson, R. Epidemiology of Epstein-Barr Virus Infection and Infectious Mononucleosis in the United Kingdom. BMC Public Health. 2020, 20(1), 1–9.
  • Odumade, O. A.; Hogquist, K. A.; Balfour, H. H. Progress and Problems in Understanding and Managing Primary Epstein-barr Virus Infections. Clin Microbiol Rev. 2011, 24(1), 193–209. DOI: https://doi.org/10.1128/CMR.00044-10.
  • Ferressini Gerpe, N. M.; Vistarop, A. G.; Moyano, A.; De Matteo, E.; Preciado, M. V.; Chabav, P. A. Distinctive EBV Infection Characteristics in Children from a Developing Country. Int. J. Infect. Dis. 2020, 93, 139–145.
  • Adland, E.; Klenerman, P.; Goulder, P.; Matthews, P. C. Ongoing Burden of Disease and Mortality from HIV/CMV Coinfection in Africa in the Antiretroviral Therapy Era. Front. Microbiol. 2010, 7, 1–9. DOI: https://doi.org/10.3389/fmicb.2015.01016.
  • Davis NL, King CC, Kourtis AP. Cytomegalovirus Infection in Pregnancy. Birth Defects Res. 2017, 109(5), 336–346. DOI: https://doi.org/10.1002/bdra.23601.
  • Manicklal, S.; Van Niekerk, A. M.; Kroon, S. M.; Hutto, C.; Novak, Z.; Pati, S. K.; Chowdhury, N.; Hsiao, N. Y.; Boppana, S. B. Birth Prevalence of Congenital Cytomegalovirus among Infants of HIV-infected Women on Prenatal Antiretroviral Prophylaxis in South Africa. Clin. Infect. Dis. 2014, 58(10), 1467–1472.
  • Tuon, F. F.; Wollmann, L. C.; Pegoraro, D.; Gouveia, A. M.; Andrejow, A. P.; Schultz, A. T.; Gomes, C. J.; Novaes, O. C.; Salmória, P. A. Seroprevalence of Toxoplasma Gondii, Cytomegalovirus and Epstein Barr Virus in 578 Tissue Donors in Brazil. J. Infect. Public Health. 2019, 12(2), 289–291. DOI: https://doi.org/10.1016/j.jiph.2018.07.001.
  • Serra, F. C.; Machado, J.; Nicola, M. H.; Jorge, M. C. A. S.; Cruz, L. E. da; Giordano, M. V.; Silva, R. O. Soroprevalência De Citomegalovírus Em Gestantes Brasileiras De Classe Socioeconômica Favorecida TT - Seroprevalence of Cytomegalovirus Infection in Pregnant Woman of Socioeconomically Advantaged Class from Brazil. DST J. bras. doenças sex. transm. 2009, 21, 12–15.
  • Instituto Brasileiro de Geografia e Estatistica (IBGE). População Estimada. Dir. Pesqui. Coord. Popul. E Indicadores Sociais, Estim. Da Popul. Resid. Com Data Ref. 1o Julho 2019. 2020.
  • Tiguman, G. M. B.; Poll, L. B.; de Castro Alves, C. E.; Pontes, G. S.; Silva, M. T.; Galvao, T. F. Seroprevalence of Cytomegalovirus and Its Coinfection with Epstein-barr Virus in Adult Residents from Manaus: A Population-based Study. Rev. Soc. Bras. Med. Trop. 2020, 53, 1–5. DOI: https://doi.org/10.1590/0037-8682-0363-2019.
  • Suntornlohanakul, R.; Wanlapakorn, N.; Vongpunsawad, S.; Thongmee, T.; Chansaenroj, J.; Poovorawan, Y. Seroprevalence of Anti-EBV IgG among Various Age Groups from Khon Kaen Province, Thailand. Asian Pac. J. Cancer Prev. 2015, 16(17), 7583–7587. DOI: https://doi.org/10.7314/APJCP.2015.16.17.7583.
  • Chaudhari, C. N.; Bindra, M. S. Seroprevalence of Cytomegalovirus among Voluntary Blood Donors. Med. J. Armed Forces India. 2009, 65(3), 252–254. DOI:https://doi.org/10.1016/S0377-1237(09)80016-6.
  • Korndewal, M. J.; Mollema, L.; Tcherniaeva, I.; van der Klis, F.; Kroes, A. C. M.; Oudesluys-Murphy, A. M.; Vossen, A. C. T. M.; de Melker, H. E Cytomegalovirus Infection in the Netherlands: Seroprevalence, Risk Factors, and Implications. J. Clin. Virol. 2015, 63, 53–58. [Internet]. DOI: https://doi.org/10.1016/j.jcv.2014.11.033.
  • Lachmann, R.; Loenenbach, A.; Waterboer, T.;; et al. Cytomegalovirus (CMV) Seroprevalence in the Adult Population of Germany. PLoS One. 2018, 13(7), 1–12.
  • Franci, G.; Crudele, V.; Della Rocca, M. T.; Melardo, C.; Chianese, A.; Finamore, E.; Bencivenga, F.; Astorri, R.; Vitiello, M.; Galdiero, E.; Galdiero, M. Epstein-Barr Virus Seroprevalence and Primary Infection at the University Hospital Luigi Vanvitelli of Naples from 2007 to 2017. Intervirology. 2019, 62(1), 15–22.
  • Alebouyeh, M.; Peller, P.; Goetz, O.; Ameri, M. A. [Comparative Study of the Prevalence of Epstein-Barr Virus Infections in Iran and Germany]. Monatsschr. Kinderheilkd. 1984, 132, 850–851
  • Chen, C. Y.; Huang, K. Y. A.; Shen, J. H.; Tsao, K. C.; Huang, Y. C. A A Large-scale Seroprevalence of Epstein-Barr Virus in Taiwan. PLoS One. 2015, 10, 1–11.
  • Crawford, D. H.; Swerdlow, A. J.; Higgins, C.; McAulay, K.; Harrison, N.; Williams, H.; Britton, K.; Macsween, K. F. Sexual History and Epstein-Barr Virus Infection. J. Infect. Dis. 2002, 186(6), 731–736.
  • Crawford, D. H.; Macsween, K. F.; Higgins, C. D.; Thomas, R.; McAulay, K.; Williams, H.; Harrison, N.; Reid, S.; Conacher, M.; Douglas, J.; Swerdlow, A. J. A Cohort Study among University Students: Identification of Risk Factors for Epstein-Barr Virus Seroconversion and Infectious Mononucleosis. Clin. Infect. Dis. 2006, 43(3), 276–282.
  • Naher H, Gissmann L, Freese UK, et al. Subclinical Epstein-Barr Virus Infection of Both the Male and Female Genital Tract--indication for Sexual Transmission. J. Invest. Dermatol. 1992, 98(5), 791–793. DOI: https://doi.org/10.1111/1523-1747.ep12499958.
  • Ramendra, R.; Isnard, S.; Lin, J.; Fombuena, B.; Ouyang, J.; Mehraj, V.; Zhang, Y.; Finkelman, M.; Costiniuk, C.; Lebouché, B.; Chartrand-Lefebvre, C.; Durand, M.; Tremblay, C.; Ancuta, P.; Boivin, G.; Routy, J. P. Cytomegalovirus Seropositivity Is Associated with Increased Microbial Translocation in People Living with Human Immunodeficiency Virus and Uninfected Controls. Clin. Infect. Dis. 2020, 71(6), 1438–1446.
  • Green, M.; Michaels, M. G. Epstein-barr Virus Infection and Posttransplant Lymphoproliferative Disorder. Am. J. Transplant. 2013, 13(s3), 41–54. DOI: https://doi.org/10.1111/ajt.12004.
  • Li, L.; Chaudhuri, A.; Weintraub, L. A.; Hsieh, F.; Shah, S.; Alexander, S.; Salvatierra, O.; Sarwal, M. M. Subclinical Cytomegalovirus and Epstein-Barr Virus Viremia are Associated with Adverse Outcomes in Pediatric Renal Transplantation. Pediatr. Transplant. 2007, 11(2), 187–195. DOI: https://doi.org/10.1111/j.1399-3046.2006.00641.x.
  • Goderis, J.; De Leenheer, E.; Smets, K.; Van Hoecke, H.; Keymeulen, A.; Dhooge, I. Hearing Loss and Congenital CMV Infection: A Systematic Review. Pediatrics; 2014;972–982.
  • Janicijevic-Petrovic, M.; SarenacVulovic, T.; Janicijevic, K.; Vujic, D.; Dejan, D.; Vulovic, D. Congenital Blindness and Visual Impairment Cause Infection or Non Infection. Mater. Soc Med. 2013, 25(2), 101. DOI: https://doi.org/10.5455/msm.2013.25.101-104.
  • Syggelou, A.; Iacovidou, N.; Kloudas, S.; Christoni, Z.; Papaevangelou, V. Congenital Cytomegalovirus Infection. Ann. N Y Acad. Sci. 2010, 1205(1), 144–147.
  • Demmler-Harrison, G. J.;. Congenital Cytomegalovirus: Public Health Action Towards Awareness, Prevention, and Treatment. J. Clin. Virol. 2009, 46, 1–5. DOI: https://doi.org/10.1016/j.jcv.2009.10.007.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.